Home > News > Midatech gets exclusivity on noble metal nanoparticles
February 5th, 2008
Midatech gets exclusivity on noble metal nanoparticles
Abstract:
The Spanish subsidiary of UK-based biological nanoparticles specialist Midatech Group has signed a licence agreement giving it new leeway to exploit the therapeutic potential of noble metal nanoparticles.
The exclusive worldwide licence from the Universidad Complutense de Madrid and the Materials Science Institute of Seville bolsters Midatech's intellectual property (IP) portfolio and opens up a range of possible applications for nanoparticles with a noble metal (e.g., gold) core, from localised drug release to cell apoptosis achieved through radiofrequency heating technology.
This latter application is of particular interest to Midatech Andalucia, which was set up in Seville to exploit the group's IP relating to magnetic noble metal nanoparticles and their interaction with external alternating magnetic fields. The Spanish subsidiary is developing a hysteresis heating device for localised destruction of bacteria and cancerous cells.
Source:
in-pharmatechnologist.com
Bookmark:
| Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Patents/IP/Tech Transfer/Licensing
Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023
Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||